Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 09, 2015 7:54 AM ET

Healthcare Equipment and Supplies

Company Overview of Ikaria, Inc.

Company Overview

Ikaria, Inc., a critical care company, focuses on developing and commercializing critical care therapeutics and interventions designed to address the significant needs of critically ill patients. It offers INOMAX (nitric oxide) for inhalation, a FDA approved inhaled nitric oxide therapy for the treatment of hypoxic respiratory failure associated with pulmonary hypertension in term and near-term infants; INOmax Total Care, a service package that delivers uninterrupted support for INOMAX (nitric oxide) for inhalation; and clinical and technical support services, which include medical affairs assistance, in-service training, and reimbursement services, as well as emergency technical, medical, a...

Perryville III Corporate Park

53 Frontage Road

Third Floor

P.O. Box 9001

Hampton, NJ 08827-9001

United States

Founded in 2006

471 Employees





Key Executives for Ikaria, Inc.

Chairman, Chief Executive Officer and President
Age: 55
Chief Financial Officer & Corporate Development and Executive Vice President
Age: 49
Chief Administrative & Operations Officer and Executive Vice President
Age: 43
Chief Scientific Officer and Executive Vice President of Research & Development
Chief Commercial Officer and Executive Vice President
Age: 49
Compensation as of Fiscal Year 2015.

Ikaria, Inc. Key Developments

Mallinckrodt public limited company, Ikaria, Inc. - M&A Call

To discuss definitive agreement under which a subsidiary of Mallinckrodt will acquire Ikaria, Inc. from a Madison Dearborn-led investor group in a transaction valued at approximately $2.3 billion

Ikaria Partners with Lee's Pharmaceutical Holdings

Ikaria, Inc. and Lee's Pharmaceutical Holdings Limited have signed a partnership agreement for the registration and commercialization of Ikaria's INOMAX(R) total care package throughout the People's Republic of China, Hong Kong, Macau and Taiwan.

Similar Private Companies By Industry

Company Name Region
Tridien Medical, Inc. United States
Sequenom Center for Molecular Medicine, LLC United States
Foundry Newco XII, Inc. United States
Zest Holdings LLC United States
International Diagnostic Systems Corp. United States

Recent Private Companies Transactions

March 5, 2015

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Ikaria, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at